HumanTrials | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

2164

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

financial buzz02/10/202103/04/2021

7688

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

financial buzz02/10/202102/10/2021

3681

Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (FRANKFURT: AGW) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has decided to review...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Technology The Market Buzz Your Environment

Moderna Prepares to Launch COVID-19 Vaccine Candidate

Rebecca Urena10/29/2020

15894

Moderna (NASDAQ: MRNA) is getting ready to publicly introduce its trial coronavirus vaccine. According to the firm, it has already accepted USD1.1 Billion in deposits from governments waiting to...

Biotechnology Healthcare Investing News Life Style Market News The Market Buzz

Johnson & Johnson Pauses Coronavirus Vaccine Trial

Rebecca Urena10/13/2020

1838

Johnson & Johnson (NYSE: JNJ), one of the pharmaceutical company’s striving to develop a COVID-19 vaccine, has paused it’s late-stage trial following an “adverse event” in one of its...

Tag: HumanTrials

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Moderna Prepares to Launch COVID-19 Vaccine Candidate

Johnson & Johnson Pauses Coronavirus Vaccine Trial

ABOUT US

Tweets